Dentsply Sirona (US) and Danaher Corporation (US) are Leading Players in the Dental Bone Graft Substitute Market
                     Dental Bone Graft Substitute Market
Global Forecast to 2025
Patient Lifting Equipment 
Market is expected to reach 
$ 659 million by 2025
Growing at a 
CAGR of  7.9% (2020 – 2025)
The global Dental bone graft substitute market size is projected to reach 
USD 659 million by 2025 from USD 450 million in 2020, at a CAGR of 7.9% 
during the forecast period.
Key Market Player
Dentsply Sirona (US), Johnson & Johnson (US), Danaher 
Corporation (US), Medtronic (Ireland), Strauman (US), Zimmer 
Dental (US) and  Geistlich Pharm (Switzerland) are the key 
players in the global dental bone graft substitute  market.
Dentsply Sirona Inc. is a leading provider of dental products. The company 
adopted acquisitions, new product launches, and agreements as its key growth 
strategies. Dentsply Sirona, the world’s largest and most diversified manufacturer 
of professional dental products and technologies, has established a new Lab 
Strategic Business Unit (SBU) incorporating the successful Laboratory CAD/CAM 
business with the renowned Dentsply Sirona Prosthetics material business. In 
accordance with this strategy, in February 2016, the company merged with 
DENTSPLY International Inc. This helped the company to expand its business and 
product offerings in the dental bone graft substitutes market.
Danaher is one of the leaders in designing, manufacturing, and marketing 
innovative products and services to professional, medical, industrial, and 
commercial customers. The company holds a significant share in the global 
dental bone graft substitute market. To maintain its market position and 
ensure future growth, the company adopts organic and inorganic growth 
strategies. In line with this, Danaher also focuses on R&D to provide its 
customers with innovative products and to maintain a competitive position in 
the market. The company’s efforts to strengthen its product portfolio, 
expand its geographic reach, and increase its brand visibility are expected 
to drive its growth in the dental bone graft substitute market.